US Site 22 — Edmond, Oklahoma

US Site 22 is a clinical research site located in Edmond, Oklahoma, United States 73013.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

US Site 22 has participated in 1 clinical trials.

Therapeutic areas: Hypertriglyceridemia, Type 2 Diabetes.

Sponsors: Afimmune.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Site 22?

US Site 22 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Site 22 conducted?

US Site 22 has 1 clinical trials on record. Their work covers Hypertriglyceridemia, Type 2 Diabetes.

Is US Site 22 accredited by Crixeo Health?

US Site 22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Site 22?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.